Optimizing Resupply To Reduce Risk Of Late Phase Delays

In this Q&A, Philip Johnston, Clinical Supply Lead at Catalent Pharma Solutions, discusses best practices for efficient and timely clinical resupply, as well as the company’s experience helping sponsors execute successful supply chain strategies. This Q&A will provide insights into how thoroughly planned resupply strategies and carefully calibrated shipment timing are crucial to maintaining clinical supply inventories as drug products enter late-stage development.